Integral Diagnostics | IDX - Cash And Equivalent


Integral Diagnostics reported AUD17.99M in Cash and Equivalent for its fiscal semester ending in December of 2023.





Cash And Equivalent Change Date
Alcidion AUD 11.8M 2.84M Jun/2024
Ansell USD 238.3M 674M Jun/2025
Cochlear AUD 275.7M 107.4M Jun/2025
CSL USD 2.16B 633M Jun/2025
Healius AUD 60.1M 25.6M Jun/2024
Mayne Pharma AUD 110.07M 838K Jun/2024
Monash IVF AUD 9.43M 1.93M Jun/2025
Nanosonics AUD 161.29M 156.45M Jun/2025
Polynovo AUD 29.21M 16.7M Dec/2025
Ramsay Health Care AUD 784.4M 443.3M Jun/2025
ResMed USD 1.66B 243.44M Mar/2026
Sigma Healthcare AUD 16.65M 3.68M Jan/2023
Sonic Healthcare AUD 645M 25.39M Jun/2024
Telix Pharmaceuticals AUD 207.16M 503.19M Jun/2025